Skip to content

Venture Capitalist Funding in Medtech Increasing


Recent reports, including one by PitchBook, indicate that both venture capitalist funding for medtech companies and the variety of medtech companies receiving venture capitalist funding has increased since the first quarter of 2023.  While venture capitalist funding for medtech companies is currently predicted to remain below the funding levels seen in 2022 and the record funding levels seen in 2021, reports suggest that venture capitalists are intrigued by new technologies in the medtech space and reports predict that investors may return to the medtech space.  Jeremy Sohn, managing general partner at P74 Ventures, stated “There’s a lot of money out there, billions and billions if not trillions of dollars sitting on the sidelines. There absolutely is money to be taken. You’ve just got to be creative.”

In one example, several companies have reportedly raised significant amounts of venture capitalist funding in 2022 including funding of $300 million, $225 million, and $223 million.  In another example, in April of 2023, Noah Medical announced that it had raised $150 million in funding to meet rising demand for its Galaxy System.

Additionally, B Capital closed its B Capital Healthcare Fund I at $500 million earlier in 2023.  Robert Mittendorff, Managing Director, General Partner and Head of Healthcare at B Capital, stated “Our target investments range between $15 million and $50 million on first check … We focus on companies with product market fit that are scaling in HealthTech and digital health, and biotech companies near or in clinical development.”  B Capital’s portfolio reportedly includes over 20 companies in various health related fields, including medtech.


, , , , ,

By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.
close modal